Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.
Get Free AccessFull Editorial Writeup
SellerForce® presents an outstanding opportunity in the Health and Wellness sector, featuring a high-performing, results-driven, non-invasive care clinic in a major Colorado metro area. Launched in 2024, this business was built on modern systems, proven treatment programs, and a clear focus on high-demand services addressing chronic pain, body contouring, and nerve-related conditions. Recognized nationally for their exceptional offerings, the clinic has established a significant market position, particularly in neuropathy care, weight management, and chronic pain relief. Their model centers on packaged treatment plans rather than one-off visits, which creates steady patient flow and predictable revenue while keeping operations simple and efficient. The business has now entered an exceptional period of momentum in 2026, building on a strong 2025 performance of $960,111 in revenue and $572,529 in SDE. As of January and February, they generate 90K in monthly revenue and have consistently delivered high performance, with monthly growth exceeding 20%. Demand trends shift throughout the year: stronger interest in body contouring early in the year and higher demand for pain and neuropathy programs later in the year help balance performance across seasons.This clinic serves roughly 150 active patients each month, with most clients in their 50s and older and an even split between men and women. Patients typically commit to structured care programs lasting 2-3 months, and about a quarter continue into maintenance or follow-up care. That ongoing engagement supports long-term value per patient and keeps treatment schedules full without relying on insurance billing. Care plans are clearly mapped out, with most programs spanning 8-12 weeks and built around multi-session packages that encourage completion and results.Key Valuation Points• Top 5 Nationally for Dahlia Red Light Utilization• $500K Net Profit• $1.05M TTM Gross Revenue• 150 Monthly Active Patients• 25% Patient Retention Post-Initial Treatment• Up To 365 Days Transition Support• Minimal Owner InvolvementTheir service mix is anchored in advanced regenerative therapies and body-contouring programs that command premium pricing. Average program values range from about $3,000 for core therapy packages to over $12,000 for specialized neuropathy programs. These services are delivered through repeatable clinical protocols, enabling trained staff to handle most day-to-day care, keeping the model scalable and less dependent on the owner. Most patients enroll in additional programs after visiting for one concern or another, thereby increasing overall patient value and strengthening retention.This clinic benefits from predictable patient demand and strong EBITDA margins. Marketing combines digital advertising, local search visibility, and strong word-of-mouth referrals. Strategic vendor relationships play a major role in lead quality and scheduling. Some partners use structured booking systems that keep calendars filled one to two weeks in advance, while others require patient deposits before visits are confirmed. In February, their dedicated team closed 80% of all cases, showing just how skilled and effective they are. With the current infrastructure and processes in place, this success rate will exceed 90%, boosting profitability while keeping owner involvement to a minimum. The owner currently spends about 20 to 25 hours per week in the business, mainly in select clinical and program-start duties that could be further delegated. The team includes a clinical therapy specialist who guides patients through treatment and enrollment, a patient experience lead who manages inbound communication and scheduling, and an office manager who oversees daily execution and reporting. Hours are currently Monday through Thursday with a half day on Friday, leaving room to extend mornings, add evening blocks, or open additional weekend slots. Margin expansion continues through smart cost-saving moves, such as cutting laundry expenses by 90% through better operations. Additionally, discretionary investments in 2025, such as coaching and mentoring programs to support long-term growth, have been introduced. Growth paths are clear and practical. Additional treatment rooms could be added in nearby space, which would allow more equipment use and higher patient volume without major changes to the core model. Hours can be expanded to capture more appointments each week, and adding a licensed medical provider would open the door to high-demand injection and hormone-based services that align well with the current patient base. The systems in place are repeatable, giving a new owner a blueprint for future locations once the first clinic is further optimized. Contact SellerForce today to explore this exceptional business opportunity!SF636
Why we like it
- Predictable cash model with high-ticket packages generating $180k monthly revenue from just 150 patients. The 8-12 week treatment programs create visibility into future cash flows, while the $3k-$12k average program values deliver strong unit economics that aren't dependent on insurance reimbursements.
- Defensible market position in growing demographic tailwinds with aging population driving chronic pain and neuropathy demand. National recognition as top 5 Dahlia Red Light clinic creates competitive moat, while the premium positioning and specialized protocols make this harder to replicate than generic healthcare services.
- Operationally scalable model with systems-dependent delivery rather than owner-dependent expertise. The repeatable clinical protocols enable staff execution of most treatments, and the current 80% close rate with structured vendor partnerships demonstrates predictable lead generation and conversion.
- Clear capacity expansion opportunities without major capital requirements. Current Monday-Thursday schedule with half-day Friday leaves obvious room for extended hours, weekend slots, or additional treatment rooms in nearby space to drive immediate revenue growth.
How to improve it
- Extend operating hours immediately to capture unmet demand, starting with full Friday operations and select evening appointments. The current schedule leaves 20-30% capacity unused, representing $200k+ annual revenue opportunity with minimal incremental costs.
- Hire licensed medical provider to add injection and hormone therapy services within first 90 days. These high-margin services align perfectly with existing 50+ patient base and could add $150k+ annual revenue per the clinic's growth projections.
- Implement systematic upselling program to increase the 25% post-treatment retention rate to 40%+ through structured maintenance packages. With 150 monthly patients, a 15% retention improvement represents $270k additional annual recurring revenue.
- Optimize vendor partnership agreements to push the 80% close rate to the projected 90% through better lead qualification and deposit requirements. This single improvement could add $120k annually in converted revenue from existing lead flow.
- Add second treatment room in nearby space to accommodate higher patient volume without operational bottlenecks. The infrastructure investment would support 200+ monthly active patients, representing $360k additional annual capacity.
- Develop systematic referral program leveraging the strong word-of-mouth reputation to reduce customer acquisition costs. Structured incentives for existing patients could reduce marketing spend while maintaining growth trajectory.
- Implement advanced scheduling and patient management software to reduce administrative overhead and improve treatment completion rates. Better systems could increase staff efficiency and patient satisfaction while reducing owner involvement.
- Explore franchise or licensing opportunities for proven treatment protocols once optimization is complete. The repeatable systems and national recognition create potential for multi-location expansion or licensing revenue streams.
Diligence notes
- Verify the claimed 20%+ monthly growth rate and validate whether January-February $90k monthly revenue represents sustainable run rate or seasonal peak. Request month-by-month revenue data for 2025-2026 to understand true growth trajectory and seasonality patterns.
- Deep dive into the vendor partnership agreements that generate leads and examine concentration risk in patient acquisition. Understand terms, exclusivity arrangements, and what happens if key vendor relationships terminate or pricing changes significantly.
- Analyze patient retention and lifetime value metrics beyond the stated 25% post-treatment retention rate. Review actual patient cohort data, average treatment completion rates, and revenue per patient over time to validate unit economics and churn assumptions.
- Examine regulatory compliance and licensing requirements for the specialized treatment protocols, particularly around the Dahlia Red Light therapy and regenerative treatments. Ensure all equipment certifications, staff licensing, and treatment protocols meet current regulatory standards and assess ongoing compliance costs.